Diamyd Medical AB (publ) reported earnings results for the full year ended August 31, 2022. For the full year, the company reported sales was SEK 0.454 million compared to SEK 0.253 million a year ago. Revenue was SEK 2.58 million compared to SEK 0.444 million a year ago.

Net loss was SEK 103.52 million compared to net income of SEK 60.05 million a year ago. Basic loss per share from continuing operations was SEK 1.4 compared to basic earnings per share from continuing operations of SEK 0.9 a year ago.